GOVINDARAJ GURRAPPA NAIDU, BALAMURUGAN VINAYAGAMURTHY, JAYANT TAPASE, NAGEEN VERMA, BARADA SHANKAR MOHANTY, NAVEEN KUMAR, BIBEK RANJAN SHOME, PARIMAL ROY
{"title":"Financial viability of Peste des Petits Ruminants (PPR) control programme (PPR-CP) implemented in Madhya Pradesh, India","authors":"GOVINDARAJ GURRAPPA NAIDU, BALAMURUGAN VINAYAGAMURTHY, JAYANT TAPASE, NAGEEN VERMA, BARADA SHANKAR MOHANTY, NAVEEN KUMAR, BIBEK RANJAN SHOME, PARIMAL ROY","doi":"10.56093/ijans.v93i11.141446","DOIUrl":null,"url":null,"abstract":"Madhya Pradesh (MP) state in India had practiced focussed vaccination against Peste des Petits Ruminants (PPR) from 2006-07 to 2015-16 and adopted PPR-Control Programme (PPR-CP) with 100% coverage during first year followed by 30% bi-annual vaccination for two years since 2016-17. This study evaluated the impact of PPR-CP using secondary data and cross-sectional survey data collected from 410 and 340 flocks before (during 2015-16, survey-I) and after PPR-CP implementation (during 2018-19, survey-II), respectively. Besides the incidence and disease cost, Incremental Benefit Cost Ratio (IBCR) was calculated to assess the financial viability of PPR- CP implementation in MP state under actual vaccination coverage after PPR-CP (scenario-I) and as per defined PPR-CP strategy (scenario-II). The number of PPR affected flocks declined significantly from 14.9% to 4.6% and the disease incidence declined from 27.5% to 10.2% in sheep and 18.8% to 0.64% in goats, in survey-I and II, respectively. The projected loss before and after PPR-CP was ` 3260 million (` 326 crore) and ` 476 million (` 47.6 crore), respectively. Financial viability of PPR-CP revealed an IBCR of 69.8:1 and 39.4:1 under scenario-I and II, respectively. Estimated incremental benefits outweighed the incremental cost in both vaccination scenarios, however, as per current vaccination plan (scenario-I), no fresh cases were reported for two years following PPR-CP, but reoccurred during 2019-20, as the state did not comply with PPR-CP Strategy. Therefore, selecting the right vaccination strategy and its diligent implementation may aid in eradicating PPR by 2030 in India in line with PPR global strategy.","PeriodicalId":13507,"journal":{"name":"Indian Journal of Animal Sciences","volume":"67 ","pages":"0"},"PeriodicalIF":0.2000,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Animal Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56093/ijans.v93i11.141446","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"AGRICULTURE, DAIRY & ANIMAL SCIENCE","Score":null,"Total":0}
引用次数: 0
Abstract
Madhya Pradesh (MP) state in India had practiced focussed vaccination against Peste des Petits Ruminants (PPR) from 2006-07 to 2015-16 and adopted PPR-Control Programme (PPR-CP) with 100% coverage during first year followed by 30% bi-annual vaccination for two years since 2016-17. This study evaluated the impact of PPR-CP using secondary data and cross-sectional survey data collected from 410 and 340 flocks before (during 2015-16, survey-I) and after PPR-CP implementation (during 2018-19, survey-II), respectively. Besides the incidence and disease cost, Incremental Benefit Cost Ratio (IBCR) was calculated to assess the financial viability of PPR- CP implementation in MP state under actual vaccination coverage after PPR-CP (scenario-I) and as per defined PPR-CP strategy (scenario-II). The number of PPR affected flocks declined significantly from 14.9% to 4.6% and the disease incidence declined from 27.5% to 10.2% in sheep and 18.8% to 0.64% in goats, in survey-I and II, respectively. The projected loss before and after PPR-CP was ` 3260 million (` 326 crore) and ` 476 million (` 47.6 crore), respectively. Financial viability of PPR-CP revealed an IBCR of 69.8:1 and 39.4:1 under scenario-I and II, respectively. Estimated incremental benefits outweighed the incremental cost in both vaccination scenarios, however, as per current vaccination plan (scenario-I), no fresh cases were reported for two years following PPR-CP, but reoccurred during 2019-20, as the state did not comply with PPR-CP Strategy. Therefore, selecting the right vaccination strategy and its diligent implementation may aid in eradicating PPR by 2030 in India in line with PPR global strategy.
期刊介绍:
Articles published in The Indian Journal of Animal Sciences encompass a broad range of research topics in animal health and production related to cattle, buffalo, sheep, goat, camel, equines, pig, rabbit, yak, mithun, poultry and fisheries. Studies involving wildlife species and laboratory animal species that address fundamental questions about their biology will also be considered for publication. All manuscripts must present some new development and must be original, timely, significant and scientifically excellent. Papers will be rejected if standards of care of, or procedures performed on animals are not up to those expected of humane veterinary scientists. At a minimum, standards must meet the International Guiding Principles for Biomedical Research involving Animals, as issued by the Council for International Organizations of Medical Sciences. (C.I.O.M.S., c/o WHO, CH 1211 Geneva 27, Switzerland). Articles reporting new animal disease must follow GOI directive as given in detail in Guidelines to Authors.